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INTRODUCTION
Between 1988 and 2012, the United States in-hospital mortality 
rate of septic patients admitted to an intensive care unit (ICU) de-
clined by 35%, despite an increase in illness severity.1 The most 
important factor in decreasing mortality among septic patients 
was the implementation of care bundle approaches (e.g., the 
Surviving Sepsis Campaign).2,3 However, sepsis is still the lead-
ing cause of death (18.4–29.0%),4,5 and the incidences of severe 
sepsis and septic shock are increasing.5,6 Therefore, much prog-
ress remains to be made in decreasing the mortality rate; one 
way to accomplish this is the early identification of patients likely 
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to die. If we can predict the mortality of patients with severe sep-
sis and/or septic shock (hereafter referred to as “severe sepsis”) in 
the emergency department (ED) and aggressively resuscitate 
them, the survival rate can be expected to increase.
Many studies have suggested prognostic factors for severe 
sepsis such as age, gender, ethnic origin, comorbidities, illness 
severity, and biomarkers associated with mortality.7,8 Conven-
tional scoring systems such as the Acute Physiology and Chron-
ic Health Evaluation II (APACHE II), Sepsis Organ Failure As-
sessment (SOFA), and National Early Warning Score (NEWS) 
have been used to predict mortality and multi-organ dysfunc-
tion.9 However, some studies considered that conventional 
scoring systems were more suitable for patients with early sep-
sis, and were unsuitable for those with severe sepsis or septic 
shock.10 Others have suggested a role for biomarkers in predict-
ing mortality from severe sepsis.11,12 More than 170 different bio-
markers have been evaluated, including coagulation, comple-
ment, contact system activation, inflammation, and apoptosis 
markers. Biomarkers can add accuracy and objectivity,13 but 
their effectiveness in mortality prediction is limited by a lack of 
specificity and sensitivity.12,14,15 It is difficult to precisely estimate 
prognosis from a single biomarker because the host immune 
response to infection is complex. Response to sepsis varies with 
time, and some specific biomarkers may be useful during spe-
cific time periods.12
Recently, some studies have reported a combinatory ap-
proach using scoring systems and biomarkers for predicting 
septic patient mortality.11,16 However, few studies suggested a 
combination of several biomarkers with and without scoring 
systems for mortality prediction in patients with severe sepsis.
Thus, the objective of this study was to determine a new no-
mogram (which is a user-friendly graphical representation of a 
statistical predictive model that generates a numerical proba-
bility of a clinical event)17 that can predict 28-day mortality in 
severe sepsis and/or septic shock patients using a combination 
of several biomarkers that are inexpensive and readily available 
in most EDs, with and without scoring systems.
MATERIALS AND METHODS
Study design and populations
We performed a retrospective, observational, registry-based 
study using the early goal-directed therapy (EGDT) registry 
data from Yonsei University College of Medicine, Severance 
Hospital, Seoul, Korea between January 1, 2012 and December 
31, 2014. Since November 2007, the protocol-based EGDT has 
been implemented as a critical pathway for patients presenting 
to the ED of our institution with severe sepsis. If a patient meet-
ing two or more systemic inflammatory response syndrome 
(SIRS) criteria along with having suspicious signs of organ dys-
function or hypoperfusion with infection presented to the ED, 
the patient’s eligibility for EGDT was assessed. Patients were 
enrolled in the EGDT registry if one or both of the following con-
ditions existed: 1) an initial systolic blood pressure (SBP) <90 
mm Hg, despite a 20 mL/kg intravenous crystalloid fluid chal-
lenge; or 2) an initial serum lactate level ≥4 mmol/L. The exclu-
sion criteria were as follows: 1) those aged <19 years, 2) preg-
nancy, 3) an acute cerebrovascular or coronary syndrome, 4) 
active gastrointestinal bleeding, 5) a contraindication to a cen-
tral venous catheter, 6) trauma, 7) a requirement for immediate 
surgical intervention, 8) a transfer to another hospital within 6 
hours after ED admission, and 9) those on do-not-resuscitate 
status. After reviewing the final diagnosis, we also excluded pa-
tients with non-infectious conditions leading to SIRS. The final 
study population was then allocated to either the training or the 
validation set at a 7:3 ratio by simple random sampling. The 
study was reviewed and approved by the Institutional Review 
Board of Yonsei University College of Medicine, Severance 
Hospital. The requirement of informed consent was waived by 
the ethics committee because of the retrospective nature of the 
study.
Data collection
One investigator (M.H.S.) collected data through a retrospec-
tive review of medical records. We attempted to use a standard-
ized data abstraction form to minimize bias in the present ret-
rospective study.
We collected demographic data, pre-existing chronic comor-
bidities, and initial vital signs including respiratory rate (RR). 
Initial laboratory data sampled at the time of ED admission that 
were known to be relevant to the diagnosis or prognosis of sep-
sis, as well as laboratory data collected routinely in the ED, were 
recorded. Parameters included white blood cell  count, hema-
tocrit, platelet count, red cell distribution width (RDW), delta 
neutrophil index (DNI), international normalized ratio, activat-
ed partial thromboplastin time (aPTT), pH, pCO2, pO2, base ex-
cess (BE), HCO3- , lactate, blood urea nitrogen (BUN), creatinine, 
albumin, creatine kinase-MB (CK-MB), troponin T, N-terminal 
Fig. 1. Flow diagram of the study subjects. ED, emergency department; 
SIRS, systemic inflammatory response syndrome.
574 patients
(admitted to the ED with severe
sepsis and/or septic shock)
Training set (393 patients)
69 deaths (17.6%)
Validation set (168 patients)
39 deaths (23.2%)
13 patients excluded
3 patients:  active gastrointestinal 
bleeding
6 patients:  requirement  
for immediate surgical 
intervention
4 patients:  non-infectious condition
 leading to SIRS
561 patients
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brain natriuretic peptide, C-reactive protein (CRP), and procal-
citonin. APACHE II score, SOFA score, and NEWS were also ob-
tained using the worst values during the initial 24 hours after ED 
admission. The primary outcome was 28-day overall mortality.
Statistical analysis
Statistical analysis was performed using SAS version 9.2 (SAS 
Inc., Cary, NC, USA). The categorical variables are described as 
frequencies (%) and continuous variables as mean±standard 
deviation.
We used independent two-sample t tests for comparisons of 
continuous variables and the chi-squared test or Fisher’s exact 
test for categorical variables. For the training set, multicollinear-
ity between the variables was taken into consideration. First, we 
created various types of combinations composed of variables 
with p<0.05 on univariate binary logistic regression, including 
individual scoring systems such as APACHE II, and then gener-
ated models using variables that were identified as indepen-
dently associated with 28-day mortality by a stepwise multivari-
ate analysis method. Subsequently, we selected the model with 
Table 1. Demographic and Other Features of the Study Population
Training set Validation set
Survivor (n=324) Deceased (n=69) p value Survivor (n=129) Deceased (n=39) p value
Age 66.5±15.0 68.0±13.7 0.454 67.9±14.4 70.6±11.4 0.278
Sex 0.591 0.132
Male 157 (48.6) 36 (52.2) 65 (50.4) 25 (64.1)
Female 166 (51.4) 33 (47.8) 64 (49.6) 14 (35.9)
SBP (mm Hg) 91.9±28.0 87.1±29.8 0.201 88.3±20.3 84.7±25.4 0.363
DBP (mm Hg) 57.3±15.0 54.5±17.9 0.240 55.5±11.5 54.2±16.9 0.663
HR (beats/min) 102.9±24.7 106.0±24.5 0.337 100.0±21.7 102.3±25.3 0.580
RR (respirations/min) 19.4±4.0 21.9±5.8 <0.001 19.5±4.1 21.7±6.2 0.046
BT (°C) 37.7±1.4 36.9±1.4 <0.001 37.8±1.6 36.9±1.5 0.003
O2 saturation (%) 94.0±8.3 91.3±11.0 0.051 95.0±6.3 88.9±10.7 0.001
WBC (/μL) 13934.4±8533.1 15733.3±13324.9 0.285 13952.0±9990.8 13023.3±11906.5 0.628
HCt (%) 35.7±7.3 34.6±7.4 0.259 35.9±6.7 33.1±6.6 0.023
RDW (%) 14.6±1.9 15.7±2.1 <0.001 14.4±2.3 15.6±1.7 0.001
PLT (103/μL) 206.0±120.7 188.4±134.2 0.280 223.0±202.8 151.3±108.7 0.005
DNI (%) 9.0±9.8 13.3±14.4 0.021 8.9±10.3 17.1±20.1 0.018
INR 1.4±1.1 1.9±2.5 0.103 1.2±0.8 1.7±1.8 0.147
aPTT (s) 33.4±9.2 39.4±19.3 0.013 32.5±7.0 38.9±17.0 0.026
CRP (mg/L) 135.5±109.5 164.9±121.4 0.049 133.7±104.8 165.6±89.4 0.094
PCT (ng/mL) 21.8±41.8 38.1±72.4 0.267 32.6±59.9 41.3±54.3 0.610
pH 7.4±0.1 7.4±0.1 0.001 7.4±0.1 7.4±0.2 0.034
pCO2 (mm Hg) 25.5±6.0 24.2±7.5 0.189 26.0±6.0 24.9±10.0 0.490
pO2 (mm Hg) 89.5±37.1 91.0±52.4 0.815 82.5±27.7 96.8±59.2 0.150
BE (mmol/L) -6.9±5.3 -10.5±6.0 <0.001 -6.9±4.6 -10.8±7.6 0.004
HCO3-  (mmol/L) 17.6±4.5 14.8±4.6 <0.001 17.6±3.7 14.8±5.6 0.004
Lactate (mmol/L) 4.1±3.3 6.0±4.0 <0.001 3.4±2.6 6.6±4.8 <0.001
BUN (mg/dL) 33.9±27.1 47.4±34.0 0.003 32.5±24.9 46.7±25.5 0.002
Cr (mg/dL) 2.1±2.1 2.4±1.9 0.192 1.9±1.9 2.9±2.2 0.005
Albumin (g/dL) 3.2±0.7 2.6±0.6 <0.001 3.2±0.7 2.7±0.6 <0.001
CK-MB (ng/mL) 3.9±10.7 8.9±17.0 0.027 4.2±8.4 10.0±14.4 0.029
Troponin T (ng/mL) 0.1±0.7 0.1±0.2 0.763 0.1±0.2 0.5±2.3 0.254
BNP (pg/mL) 5319.1±9100.0 8285.2±11049.1 0.059 4005.8±6617.8 9148.4±11225.1 0.041
Comorbidities
DM 123 (38.0) 25 (36.2) 0.788 45 (34.9) 17 (43.6) 0.324
CRF 34 (10.5) 12 (17.4) 0.106 13 (10.1) 10 (25.6) 0.013
CHF 18 (5.6) 5 (7.3) 0.574 12 (9.3) 1 (2.6) 0.303
COPD 16 (5.0) 6 (8.7) 0.246 6 (4.7) 3 (7.7) 0.435
LC 10 (3.1) 3 (4.4) 0.708 3 (2.3) 4 (10.3) 0.052
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the largest area under the receiver operating characteristic curve 
(AUC). The Delong method was used to compare the AUC for 
the predictive value of the new nomogram with those of 
APACHE II, NEWS, and SOFA regarding 28-day survival of pa-
tients with severe sepsis. Finally, a simplified nomogram was 
developed for the prediction of 28-day mortality with the train-
ing set using variables included in the selected model. The per-
formances of the nomograms in predicting outcomes were 
evaluated with respect to discrimination and calibration.17 The 
Hosmer-Lemeshow goodness-of-fit test was used to assess the 
suitability of the models, because it showed how well the no-
mogram was calibrated; namely, a close approximation be-
tween the observed and predicted probabilities shows good 
calibration and confirms the exportability of the model. There-
after, the diagnostic accuracy of the new nomogram generated 
with the training set was subsequently tested in the validation 
set. p<0.05 was considered statistically significant.
RESULTS
Study population
A total of 574 patients with suspected severe sepsis underwent 
EGDT in the ED during the study period and were initially en-
rolled in the present study. Upon chart review, we excluded 13 
patients for the following reasons: active gastrointestinal bleed-
ing (n=3), a requirement for immediate surgical intervention 
(n=6), and a non-infectious condition leading to SIRS (n=4) 
(Fig. 1). We included 561 patients in the final analysis, of whom 
393 were randomly allocated to the training set and 168 to the 
validation set. The baseline characteristics in the training and 
validation sets that were related to 28-day mortality are sum-
marized in Table 1. In the training set of 393 patients, 69 (17.6%) 
did not survive 28 days. Moreover, there were 39 (23.2%) deaths 
during the follow-up period in the validation set.
Albumin, base excess, and respiratory rate are 
independent prognostic factors in the training set
Among training set patients, the RR of those who died was 
higher than that of survivors (21.9±5.8 vs. 19.4±4.0; p<0.001), 
and body temperature was also significantly different between 
the groups (p<0.001). There were several differing laboratory 
findings between the surviving and deceased groups. High RDW, 
DNI, aPTT, and CRP values were correlated with increased 28-
day mortality in severely septic patients (p<0.001, p=0.021, 
p=0.013, and p=0.049, respectively). Low pH, HCO3- , and BE 
Table 1. Demographic and Other Features of the Study Population (Continued)
Training set Validation set
Survivor (n=324) Deceased (n=69) p value Survivor (n=129) Deceased (n=39) p value
Infection site <0.001 0.051
Lung 62 (19.1) 31 (44.9) <0.001 25 (19.4) 14 (35.9) 0.032
Intra-abdominal 88 (27.2) 11 (15.9) 0.051 40 (31.0) 8 (20.5) 0.049
Urinary tract 101 (31.2) 7 (10.1) <0.001 41 (31.8) 6 (15.4) 0.046
Multiple 16 (4.9) 4 (5.8) 0.764 6 (4.7) 2 (5.1) >0.999
Others 57 (17.6) 16 (23.2) 0.278 17 (13.2) 9 (23.1) 0.134
APACHE II score 16.0±5.3 18.5±6.1 <0.001 16.0±5.1 21.1±6.5 <0.001
NEWS 8.5±3.0 9.7±3.7 0.011 8.7±2.8 10.7±2.7 <0.001
SOFA 6.4±2.5 7.2±2.7 0.015 6.7±2.1 8.5±2.3 <0.001
SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; RR, respiratory rate; BT, body temperature; WBC, white blood cell; HCt, hematocrit; 
RDW, red cell distribution width; PLT, platelet count; INR, international normalized ratio; aPTT, activated partial thromboplastin time; DNI, delta neutrophil index; 
CRP, C-reactive protein; PCT, procalcitonin; BE, base excess; BUN, blood urea nitrogen; Cr, creatinine; CK-MB, creatine kinase-MB; BNP, N-terminal brain natri-
uretic peptide; DM, diabetes mellitus; CRF, chronic renal failure; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; LC, liver cirrhosis; 
APACHE II, Acute Physiology and Chronic Health Evaluation II; NEWS, National Early Warning Score; SOFA, Sepsis Organ Failure Assessment.
Data are expressed as the mean±SD or n (%). There were no differences between the training set and the validation set except for SOFA. 
Table 2. A Multivariate Analysis Predicting 28-Day Mortality in Septic Patients from the Training Set 
Model 1 (AUC: 0.7901) Model 2 (AUC: 0.7901) Model 3 (AUC: 0.8173) Model 4 (AUC: 0.8173)
OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value
Albumin 0.276 (0.178–0.427) <0.001 0.276 (0.178–0.427) <0.001 0.254 (0.161–0.403) <0.001 0.254 (0.161–0.403) <0.001
BE 0.899 (0.856–0.944) <0.001 0.899 (0.856–0.944) <0.001 0.901 (0.856–0.948) <0.001 0.901 (0.856–0.948) <0.001
RR 1.119 (1.057–1.183) <0.001 1.119 (1.057–1.183) <0.001
AUC, area under the receiver operating characteristic curve; OR, odds ratio; CI, confidence interval; BE, base excess; RR, respiratory rate; APACHE II, Acute Phys-
iology and Chronic Health Evaluation II; SOFA, Sepsis Organ Failure Assessment; NEWS, National Early Warning Score.
Each scoring system was entered individually into the multivariate logistic regression analysis with clinical variables and laboratory variables in the training set. 
A total of four models were generated by a stepwise multivariate analysis method. Model 1 includes clinical variables, laboratory variables, and APACHE II; 
Model 2 includes clinical variables, laboratory variables, and NEWS; Model 3 includes clinical variables, laboratory variables, and SOFA; and Model 4 includes 
clinical variables and laboratory variables without a scoring system.
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values as well as a high lactate value were also significantly as-
sociated with increased 28-day mortality (p=0.001, p<0.001, 
p<0.001, and p<0.001, respectively). Low albumin, high BUN, 
and high CK-MB values were predictive of increased mortality 
(p<0.001, p=0.003, and p=0.027, respectively). Procalcitonin 
values were available for only 150 patients (38.2%) because this 
test was not performed during the earlier stage of the study pe-
riod, and did not show statistical significance predicting 28-day 
mortality in our study (p=0.267). In the training set, the 
APACHE II, NEWS, and SOFA scores of deceased patients were 
higher than those of survivors (18.5±6.1 vs. 16.0±5.3; p<0.001, 
9.7±3.7 vs. 8.5±3.0; p=0.011, and 7.2±2.7 vs. 6.4±2.5; p=0.015, re-
spectively) (Table 1).
All significant variables in the univariate binary logistic re-
gression were considered when generating models to predict 
28-day mortality in patients with severe sepsis. Each scoring 
system was entered individually into the multivariate logistic 
regression analysis with clinical variables and laboratory vari-
ables among the training set (models 1–3). We also created a 
model that did not include a scoring system (model 4). Conse-
quently, four models were generated by a stepwise multivariate 
analysis method in our study. Because pH is highly correlated 
with HCO3- , this variable was dropped from subsequent mod-
els. Table 2 summarizes the results of the multivariate logistic 
regression analysis. In the models that included scoring sys-
tems, the multivariate logistic analysis revealed that no scoring 
system was associated with 28-day mortality in patients with 
severe sepsis. Model 4, which did not include a scoring system, 
demonstrated the largest AUC value of 0.8173 (95% CI, 0.7605–
0.8741) among the models. This model was composed of albu-
min, BE, and RR as predictive factors and showed a significant-
ly higher AUC value than those of conventional scoring systems 
(p<0.001) (Fig. 2).
Nomogram shows that hypoalbuminemia, low base 
excess values, and tachypnea predict 28-day mortality
A nomogram incorporating three prognostic factors was estab-
lished from the final model (Fig. 3). The nomogram illustrated 
that albumin was the largest contributor to prognosis, followed 
by BE and RR. By calculating the total number of points and lo-
cating it on the total point scale, we were easily able to draw a 
straight line down to estimate the predicted probability of 28-
day mortality. For example, a 55-year-old man presented with 
complaints of a 3-day history of fever associated with pneumo-
nia. On admission, he presented with tachypnea [20/min (15 
points)] and his blood test results were BE=-10 mmol/L (43 
points) and albumin=2 g/dL (78 points). The sum of the nomo-
gram values was 136, and the predicted probability for 28-day 
mortality was 43%.
The p value from the Hosmer-Lemeshow test was 0.61 for 
model 4, indicating that the model was suitable. In the valida-
tion set, discrimination was good with an AUC value of 0.7537 
(95% CI, 0.6563–0.8512). The calibration plot of the nomogram 
presented excellent agreement between predicted and ob-
served probabilities of 28-day mortality, and exhibited a close 
approximation between the probabilities.
DISCUSSION
In this study, we developed and validated a new nomogram us-
ing three independent variables to identify 28-day mortality in 
patients with severe sepsis in the ED. This nomogram is solely 
based on hypoalbuminemia, a low BE value, and tachypnea, 
which are easily and readily obtainable during the patient’s 
course in the ED. Therefore, it can be used to identify patients 
who are at high risk of severe sepsis and require more aggres-
sive treatment. Our nomogram demonstrated a significantly 
higher AUC value than those of conventional scoring systems, 
despite it being simpler than such systems.
We found that the initial albumin value sampled at the time 
of ED admission was associated with 28-day mortality in severe 
sepsis patients and was the largest contributor to prognosis. Al-
bumin, which is considered a negative acute-phase protein, is 
frequently decreased in the acute phase of several diseases 
Fig. 2. Comparisons of APACHE II, NEWS, and SOFA scores versus model 
4 in predicting 28-day mortality. Model 4 was composed of albumin, BE, 
and RR as predictive factors, and showed an AUC value of 0.8173 (95% CI, 
0.7605–0.8741). The AUCs of the APACHE II, NEWS, and SOFA scores 
were 0.6177 (95% CI, 0.5423–0.6931), 0.5940 (95% CI, 0.5137–0.6743), and 
0.6005 (95% CI, 0.5256–0.6754), respectively. Model 4 demonstrated a sig-
nificantly higher AUC value than those of conventional scoring systems 
(p<0.001) by the Delong test for comparisons of receiver operating char-
acteristic curves. APACHE II, Acute Physiology and Chronic Health Evalu-
ation II; NEWS, National Early Warning Score; SOFA, Sepsis Organ Fail-
ure Assessment; BE, base excess; RR, respiratory rate; AUC, area under 
the curve; CI, confidence interval.
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such as sepsis or trauma, and its levels are reduced by approxi-
mately 10–15 g/L within 1 week of the event.18 Hypoalbumin-
emia can be caused by reduced hepatic synthesis, a decrease in 
the supply of amino acids, increased leakage into the interstitial 
space, and tissue catabolism or distributional issues.19 The re-
duction in albumin synthesis during inflammation is likely as-
sociated with the effect of monocytic products such as interleu-
kin-6 and tumor necrosis factor-α.20 Although the precise 
mechanisms have not been fully described, serum albumin has 
protective effects such as maintaining physiologic homeostasis, 
antioxidant activity, anti-inflammatory effects, and prevention 
of apoptosis.21,22 Therefore, these protective biologic functions 
may be impaired in hypoalbuminemic conditions, and in-
creased morbidity and mortality can consequently develop in 
severely septic patients.23,24 In patients with community-ac-
quired bloodstream infection who require intensive care, hypo-
albuminemia was an independent risk factor associated with 
global mortality (odds ratio, 0.34; 95% CI, 0.15–0.76).23 A previ-
ous study by Vincent, et al.24 also reported that each 10 g/L de-
cline in serum albumin concentration significantly raised the 
odds of mortality by 137%, morbidity by 89%, prolonged ICU 
stay by 28%, prolonged hospital stay by 71%, and increased re-
source utilization by 66%.
BE was defined as the concentration of titratable hydrogen 
ion required to return the pH to 7.4 while maintaining PCO2 at 
40 mm Hg by equilibration.25 BE can be correlated with the lev-
Fig. 3. The newly developed nomogram and external validation. (A) A nomogram for predicting 28-day mortality among patients with severe sepsis and/or 
septic shock using the training set. (B and C) External validation of the nomograms using the validation set. The discriminative ability of the nomogram 
was good, with an AUC value of 0.7537 (95% CI, 0.6563–0.8512) (B). Calibration plots (dotted line) show close approximations to the logistic calibration (solid 
line), indicating good agreement between the predicted and observed probabilities of 28-day mortality (C). BE, base excess; RR, respiratory rate; AUC, 
area under the curve; CI, confidence interval. 
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el of deterioration secondary to severe sepsis. The decrease in 
BE during septic shock is associated with critical reductions in 
oxygen use, resulting in tissue hypoperfusion, anaerobic me-
tabolism, and lactic acidosis.26 Moreover, these were related to 
mortality in patients with severe sepsis.27 In this study, the ini-
tial BE was -6.9±5.3 and -6.9±4.6 mmol/L in survivors vs. 
-10.5±6.0 and -10.8±7.6 mmol/L in non-survivors in the train-
ing and validation sets (p<0.001 and p=0.004), respectively. This 
result is consistent with a previous study.28 Some scoring sys-
tems used pH and lactate values to evaluate metabolic acidosis 
with tissue hypoperfusion.29,30 However, BE has been shown to 
be superior to pH for evaluating metabolic acidosis. Davis, et 
al.31 reported that BE was superior to pH as a marker of meta-
bolic acidosis clearance after shock in a retrospective study of 
674 patients. Similarly, BE is superior to lactate, because lactate 
does not entirely account for metabolic acidosis development 
from systemic hypoperfusion.27 Accordingly, our scoring sys-
tem more accurately estimated metabolic acidosis in patients 
with severe sepsis by using the BE value.
Tachypnea is a compensatory mechanism for metabolic aci-
dosis secondary to sepsis. Respiratory difficulty (defined as 
tachypnea, low oxygen saturation, or high oxygen requirement) 
was significantly predictive of mortality in septic patients; 
therefore, recent scoring systems such as the Mortality in Emer-
gency Department Sepsis (MEDS) and Predisposition Insult 
Response and Organ Failure (PIRO) incorporated tachypnea as 
a key criterion.30,32 In our study, the respiratory rates of deceased 
patients were 21.9±5.8 in the training set and 21.7±6.2 in the 
validation set. These results met the tachypneic criteria of the 
MEDS and PIRO systems.
There are several scoring systems to predict outcomes of se-
vere sepsis patients, with APACHE II and SOFA being the most 
popular. However, the predictive ability of these conventional 
scoring systems was somewhat suboptimal; the AUC for 
APACHE II was 0.71,33 and that for SOFA was 0.708,34 in previ-
ous reports. In our study, the AUC values of APACHE II, NEWS, 
and SOFA were 0.618, 0.594, and 0.601, respectively; these val-
ues were significantly lower than those of our new nomogram. 
One explanation for this outcome may be that the conventional 
scoring systems were designed for patients in the ICU, not for 
those in the ED as our nomogram was.
Our new scoring system carries the virtues of simplicity and 
promptitude to predict 28-day mortality in patients with severe 
sepsis in the ED. In this study, the variables selected in models 
3 and 4 were the same; hence, the AUCs of these two models 
were the same as well. For the simplicity and promptitude of our 
new scoring system, we ultimately selected model 4, as it does 
not include the conventional, complex scoring system. Further-
more, by building a user-friendly nomogram, our system is 
more readily available, and predicting mortality in severely sep-
tic patients is easier to calculate than with other conventional 
scoring systems. Our nomogram uses the initial values of vari-
ables rather than the worst values; therefore, we are able to pre-
dict mortality earlier, which can be helpful for selecting high-
risk patients who require more aggressive interventions. Several 
studies reported that early, intensive, and effective treatment 
could decrease the mortality rate by 8–16%.35 Therefore, our no-
mogram could be applied to triage decisions, and could be 
used to select severely ill patients for closer monitoring and ag-
gressive treatment. Additionally, our nomogram includes only 
three independent variables, while others include a greater 
number of variables and are thus much more complex to cal-
culate. Our nomogram could be performed significantly more 
predictably than other scoring systems, with AUCs of 0.8173 
from the training set and 0.7537 from the validation set.
This study has several limitations. The main limitation is that 
it is a retrospective study of data collected from a single center; 
therefore, it is possible that the results could differ from those of 
other centers, and the predictive probability could be overesti-
mated compared to a prospective study. Although we per-
formed internal validation to reduce bias, a multi-center study 
is required for further validation. Another source of bias was the 
population enrollment criteria, in which organ dysfunction and 
hypoperfusion were regarded as an initial SBP of <90 mm Hg, 
despite a 20 mL/kg intravenous crystalloid fluid challenge; or 
an initial serum lactate level ≥4 mmol/L. These criteria did not 
completely encompass severe sepsis; however, lactate is a com-
monly used marker of hypoxic tissue.36 Accordingly, these pa-
tients could be regarded as severely septic in our study. Our no-
mogram did not include information such as the cause of 
infection or the type of cultured pathogen. However, our goal 
was to construct a system to predict mortality among patients 
with severe sepsis, but not to identify a specific infection or 
pathogen. We performed comparisons with conventional scor-
ing systems, such as APACHE II, NEWS, and SOFA, but these 
scoring systems are not intended for use in ED environments. 
However, MEDS, Mortality In Severe Sepsis in the Emergency 
Department, and PIRO have been developed for use in the ED 
to risk-stratify septic cases.30,32,37 In a future study, we aim to com-
pare these scoring systems to ours, and to extend the validation 
to a multi-center study. An increase in treatment bundle com-
pliance improves the outcome of severe sepsis patients.38,39 
However, we could not accurately measure the compliance rate 
of EGDT at our institution because of the retrospective nature 
of this study. The overall mortality rate of our study population 
was similar to that of a recently published randomized con-
trolled study,40 indicating that our compliance rate was not nec-
essarily lower than that observed in a developed country.
In conclusion, our new nomogram is valuable in predicting 
the 28-day mortality of patients with severe sepsis and/or septic 
shock at an early stage after ED admission, and it is superior to 
the APACHE II, NEWS, and SOFA scoring systems in predicting 
mortality, and is readily available.
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